1. 119P Final results of phase II trial (MIRACULUM) of the novel PD-1 inhibitor prolgolimab in patients with advanced melanoma. (15th December 2019) Authors: Tjulandin, S; Fedyanin, M; Demidov, L; Moiseyenko, V; Protsenko, S; Odintsova, S; Semiglazova, T Y; Zukov, R; Lazarev, S; Andreev, A; Nechaeva, M; Makarova, J; Fadeeva, N; Tarasova, A; Kozlova, O; Shustova, M; Garipov, A; Ivanov, R Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A theoretical approach for the reduction of X-ray radiation dose within the optimization of the tomographic scanning process. (October 2019) Authors: Ozdiev, A; Lazarev, S Journal: Journal of physics Issue: Volume 1327(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bragg coherent x-ray diffractive imaging of a single indium phosphide nanowire. (6th May 2016) Authors: Dzhigaev, D; Shabalin, A; Stankevič, T; Lorenz, U; Kurta, R P; Seiboth, F; Wallentin, J; Singer, A; Lazarev, S; Yefanov, O M; Borgström, M; Strikhanov, M N; Samuelson, L; Falkenberg, G; Schroer, C G; Mikkelsen, A; Feidenhans'l, R; Vartanyants, I A Journal: Journal of optics Issue: Volume 18:Number 6(2016:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗